SEC Form D · filed August 3, 2020
AmbAgon Therapeutics Inc
Location
SAN FRANCISCO, CA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
Margarita Chavez · San Francisco, CADirectorJanwillem Naesens · San Francisco, CADirectorPeter Dudek · San Francisco, CADirectorRoel Bulthuis · San Francisco, CADirectorChristian Ottmann · San Francisco, CAExecMichelle Arkin · San Francisco, CAExec · DirectorAdam Rosenberg · San Francisco, CADirectorDonald R. Young · Northborough, MADirectorAjay Gupta · CHRISTCHURCH, Q2DirectorYaniv Tepper · Los Angeles, CADirectorAndrew E. Spring · New York, NYExec · DirectorLawrence J. Konis · Santa Monica, CAExecJ. E. Virtue · New York, NYDirectorSteven R. Mitchell · Northborough, MADirectorLucas Brunsveld · San Francisco, CAExecMamoon Hamid · San Francisco, CADirectorJoshua Merrill · San Francisco, CAExecCraig Kautsch · Fort Worth, TXExec · DirectorRichard Wahlstedt · Chicago, ILDirectorJoseph King · Chicago, ILDirectorMark D. Allsteadt · NORWALK, CTDirectorDavid Festi · Washington, PADirectorLucas Brunsveld · San Francisco, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗